Woo studying Flashcards
Light criteria defining exudative pleural effusion
At least 1 of the following:
[Pleural fluid protein]/[Serum protein] > 0.5
[Pleural fluid LDH]/[Serum LDH] > 0.6
Pleural fluid LDH > 2/3 upper limit of nml serum LDH
Anti-AChR
Myasthenia gravis
Anti-basement membrane
Goodpasture syndrome
Anti-cardiolipin
SLE,
Antiphospholipid syndrome
Anti-centromere
Limited scleroderma (CREST syndrome = Calcinosis, Raynaud’s, Esophageal dysmotility, Sclerodactyly, Telangiectasias)
Anti-desmosome
Pemphigus vulgaris (Includes oral mucosa, +Nikolsky's, Intraepidermal IC deposits) PemphiguS = Superficial
Anti-hemidesmosome
Bullous pemphigoid (Spares oral mucosa, -Nikolsky's, Epidermal-dermal jxn IC deposits) PemphigoiD = Deep
Anti-dsDNA, Anti-Smith
SLE
Anti-glutamic acid decarboxylase
T1DM
Anti-histone
Drug-induced SLE
Anti-Jo-1, Anti-SRP, Anti-Mi-2
Polymyositis, Dermatomyositis
Anti-microsomal
Hashimoto thyroiditis (also anti-TG)
Anti-mitochondrial
Primary biliary cirrhosis
ANA
Nonspecific (SLE usually)
Anti-parietal cell
Pernicious anemia
Anti-Scl-70
(AKA anti-DNA topoisomerase I)
Diffuse scleroderma
Anti-smooth muscle
Autoimmune hepatitis
Anti-SSA/-SSB
Sjogren’s syndrome
Anti-TSHR
Graves’ disease
Anti-U1 RNP
Mixed CT disease
IgA anti-endomysial/-tissue transglutaminase
Celiac disease
p-ANCA
(AKA MPO-ANCA)
Micro-PAN, eosinophilic granulomatosis w/ polyangiitis (Churg-Strauss syndrome)
c-ANCA
(AKA PR3-ANKA)
Wegener’s granulomatosis w/ polyangiitis
IgM targeting IgG Fc region
(AKA RF)
RA
(RF is not as specific for RA as anti-CCP)
Febrile nonhemolytic transfusion rxn
1-6h post-transfusion
Fever/chills
Due to cytokine accumulation during storage
Acute hemolytic transfusion rxn
Within 1h post-transfusion
Fever, flank pain, hemoglobinuria, AKI, DIC
Due to ABO incompatibility
Positive direct Coombs
Delayed hemolytic transfusion rxn
2-10d post-transfusion
Mild fever, hemolytic anemia
Due to anamnestic Ab response
Positive direct Coombs, Positive new Ab response
Anaphylactic transfusion rxn
Rapid onset (sec-mins) shock, angioedema/urticaria, respiratory distress Due to recipient anti-IgA Abs
Urticarial/allergic transfusion rxn
2-3h post-transfusion
Urticaria, flushing, angioedema, pruritus
Due to recipient IgE Abs, mast cell activation
Transfusion-related acute lung injury
Within 6h post-transfusion
Respiratory distress, noncardiogenic pulm edema
Due to donor anti-leukocyte Abs
Pleural fluid pH
Normal ~7.60
Transudative 7.4-7.55
Exudative below 7.45
TTP cause, symptoms, treatment
(Thrombotic thrombocytopenic purpura)
Due to acquired autoAb against ADAMTS13 (would cleave vWF from endothelium; plts get caught near endothelium and form microthrombi)
Fever, Neurologic changes, AKI, MAHA, Thrombocytopenia
Treat w/ plasma exchange; 9/10 die w/o treatment
HIT cause, symptoms, risk
Due to Abs against PF4-Hep complex which activates plts to cause thrombus formation and plt consumption –> thrombocytopenia, venous/arterial thrombi, necrosis at heparin sc injection site, anaphylaxis to injections
Highest risk w/ unfractionated heparin
Metabolic alkalosis ddx
Low (vomiting, prior diuretics) vs High urine Cl
If high urine Cl, hypervolemic (excess mineralocorticoid activity: hyperaldosteronism, Cushing’s, ectopic ACTH) vs hypo-/euvolemic (Current diuretics vs Bartter, Gitelman)
Vomiting, diuretics are saline-responsive
Mineralocorticoid or renal syndromes are saline-unresponsive
SIADH labs
Serum diluted: Hyponatremia Hypotonic serum (under 275mOsm)
Urine concentrated: Urine osmolarity over 100
Urine Na over 40
Dermatomyositis symptoms, disease associations
Proximal symmetric extremity weakness
Heliotrope rash, Gottron’s papules (scales over joints), CPK over 10x ULN
Assoc w/ internal malignancies - do age appropriate screenings
Lactose intolerance test
Lactose hydrogen breath test
Leukomoid rxn vs CML
Leukomoid rxn:
WBC over 50, High LAP, Mature PMN precursors, No basophilia
CML:
WBC over 100, Low LAP, Immature PMN precursors, Basophilia
Trihexyphenidyl
Anticholinergic Rx for symptomatic Parkinson’s
May cause acute angle closure glaucoma
AIHA vs Hereditary spherocytosis
AIHA has a negative FHx and positive Coombs’ test
Difference between case-control and retrospective cohort studies
Case-control: Determine outcome first, then look for associated risks
Retrospective cohort: First ascertain risk exposure, then determine outcome
Expected FEV1 change with bronchodilators in asthma
At least 12%
Acid-base compensations
MetAc: Winter’s formula (Exp paCO2 = 1.5 * [HCO3=] + 8 +/-2)
MetAlk: Exp PaCO2 +0.7 for every +1 HCO3-
Acute RespAc: Serum HCO3- +1 for every +10 PaCO2
Acute RespAlk: Serum HCO3- -2 for every -10 PaCO2
D-xylose test
Monosaccharide absorbed in proximal small bowel without degradation by pancreatic or brush border enzymes before urinary excretion
Low abs = proximal small bowel disease (Celiac’s)
Cross-sectional study
Collects data from a group of people to assess disease frequency at a particular point in time
May show risk association, but not causality
“What’s happening?”
Measures prevalence
Case-control study
Compares group with disease to a group without disease
Looks for prior exposure/risk
Retrospective
“What happened?”
Measures odds ratio: OR = [(a/c)/(b/d)] = (ad)/(bc)
Cohort study
Compares initially disease-free people in two groups to see who develops disease: one with exposure/risk, and one without exposure/risk
Can show if exposure/risk increases disease likelihood
Retrospective OR prospective
“Who will develop/developed disease?”
Measures relative risk: RR = [a/(a+b)]/[c/(c+d)]
Twin concordance, adoption studies
Measure heritability and environmental influence
Mono- vs dizygotic twins
Siblings with biological vs adoptive parents
Clinical trial phase goals
I: Is it safe?
II: Does it work?
III: Is it as good or better than current treatments?
IV: Can it stay?
Odds ratio
Odds that a group with disease was exposed to a risk divided by the odds that the group without the disease was exposed
OR = (a/c)/(b/d) = (ad)/(bc)
Typically used for case-control studies
Relative risk
Risk of developing disease in the exposed group divided by risk in the unexposed group
RR = [a/(a+b)]/[c/(c+d)]
Typically used in cohort studies
If prevalence is low, OR ~ RR
Attributable risk
Difference in risk between exposed and unexposed groups, i.e. proportion of disease occurrences attributable to an exposure
AR = a/(a+b) - c/(c+d)
Relative risk reduction
Proportion of risk reduction attributable to an intervention as compared to a control
RRR = 1 - RR = 1 - [a/(a+b)]/[c/(c+d)]
Absolute risk reduction
Difference in risk attributable to the intervention as compared to the control
ARR = c/(c+d) - a/(a+b) = -AR
Number needed to treat
NNT = 1/ARR (treat has more letters than harm)
Number needed to harm
NNH = 1/AR
Recruiting biases, examples, fix
Selection, sampling, referral, allocation bias
E.g. Berkson bias - study population is from a hospital and less healthy than the general population
Healthy worker effect - (opposite of Berkson)
Non-response/differential f/u - nonrespondents may differ from participants meaningfully
Randomize to reduce
Procedure bias, example, fix
Subjects in different groups are not treated the same
Includes detection bias: Those with a risk factor undergo greater diagnostic scrutiny than those without the risk
Use blinding and placebos to reduce
Recall bias, fix
Awareness of disorder alters recall by subjects
Common in retrospective studies
Decrease time from exposure to follow-up to reduce
Observer-expectancy bias, example, fix
Researcher’s belief in a treatment’s efficacy changes outcomes
AKA Pygmalion effect or self-fulfilling prophecy
Use blinding and placebos to reduce
Confounding bias, fixes
Factor is related to both exposure and outcome, but not the causal pathway
Reduce with multiple/repeat studies, matching of patients with similar characteristics in both control and treatment groups, crossover studies where subjects act as their own controls
Lead-time bias, fix
Early detection is confused with increased survival
Especially important for studies of long-term chronic disease
Reduce by measuring back-end survival by controlling for disease severity at time of diagnosis
Hawthorne effect
AKA observer effect
Subjects tend to change their behavior when they know they’re being observed
alpha definition
Probability of making a type I error (finding a difference between control and experimental groups when one does not exist)
beta definition
Probability of making a type II error (stating there is no difference between control and experimental groups when one does exist)
beta increases as alpha decreases
Power
1 - b
Increases as beta decreases: Increased precision, increased effect, or INCREASED SAMPLE SIZE
t-test
Checks differences between the MEANS OF 2 GROUPS
E.g. BP between males/females
ANOVA
Checks differences between the MEANS OF AT LEAST 3 GROUPS
E.g. BP between members of 3 ethnic groups
Chi-square test
Checks differences between 2 or more PERCENTAGES OR PROPORTIONS OF CATEGORICAL OUTCOMES
E.g. Percentage of members of 3 ethnic groups with HTN
Ordinal data
Data ordered by a position on a scale
Usually categorical - cannot perform arithmetic with these
E.g. Runners finishing in 1st, 3rd, 5th places
Qualitative - Non-parametric
Interval data
Data measured along a scale in which each position is equidistant
Quantitative - Parametric
Allows for distances between data points to be equivalent in a way
E.g. Happiness scale from 1-10 or Runners finishing a 5k between 18:00-18:59, 19:00-19:59, 20:00-20:59, etc.
Nominal data
Data differentiated by a simple naming system
Usually categorical - E.g. “employee”
May have a number assigned, but is not ordinal (E.g. Runner’s ID number or an athlete’s jersey number)
Qualitative - Non-parametric
Ratio data
Data in which numbers are multiples of each other and can be mathematically compared. Zero has a meaning on the scale used for this data
E.g. Runner’s finishing time for a race
Quantitative - Parametric
Continuous data
Measured along a continuous scale allowing for infinitely fine subdivision
Vs. discrete where data falls into bins like with interval data
Parametric data
Quantitative, forms predictable distributions (e.g. normal)
Can use arithmetic to gain insight into the datasets
Non-parametric data
Qualitative, does not assume any distribution
Likelihood ratio for a positive test
Sensitivity/(1-Specificity)
Likelihood ratio for a negative test
(1-Sensitivity)/Specificity
Sensitivity
Chance a test detects disease when it is present
(True-positive rate)
a/(a+c)
TP/(TP+FN)
Specificity
Chance a test indicates no disease when none is present
(True-negative rate)
d/(b+d)
TN/(TN+FP)
Positive predictive value
Proportion of positive test results that are true positives
a/(a+b)
TP/(TP+FP)
Negative predictive value
Proportion of negative test results that are true negatives
d/(c+d)
TN/(TN+FN)
Incidence
New cases occuring during a particular time period
N(new cases)/N(at risk)
Prevalence
Number of people affected by a disease at a given point in time
N(w/disease)/N(population)
Increases w/ incidence
Decreases w/ death of affecteds and recovery
Standard error of the mean
Used for samples of a population
SEM = s/sqrt(n), where s = stddev of sample
Correlation coefficient
r
Always between -1 and 1
More negative = stronger negative correlation, etc.
Coefficient of determination
r^2
Always between 0 and 1
Represents the amount of variance in the dependent variable (y) due to the independent variable (x):
y = a + bx
Psych Rx SEs
1st gen: Extrapyramidal symptoms, hyperprolactinemia (also risperidone)
2nd gen: Metabolic syndrome (weight gain, dyslipidemia, new T2DM) - esp. olanzapine, clozapine
Ziprasidone - Long QT
Clozapine indications, SE
Treatment-resistant or suicidal schizophrenia
SE: Agranulocytosis, SZ, myocarditis, metabolic syndrome
DSM-5 psychosis disorders
Brief psychotic - less than 1m w/ full return of fxn
Delusional - delusions over 1m w/o other psychotic symptoms and w/ nml fxn
Schizophreniform - less than 6m of schizophrenic sx
Schizophrenia - at least 6m w/ 1m active sx and functional decline
Schizoaffective - Schizophrenia + concurrent mood episode + at least 2w psychosis w/o mood sx
Major depression signs and symptoms
SIGECAPS Sleep changes Interest deficit (anhedonia) Guilt Energy deficit Concentration deficit Appetite changes Psychomotor changes Suicidality
Depressed mood ddx
Major depressive disorder - at least 2w, 5 of SIGECPAS, fxn impairment, no mania/drug/medical hx
Adjustment disorder w/ depressed mood - Within 3m of identifiable stressor
Normal stress response - Not excessive, no fxn impairment
Bipolar 1 vs Bipolar 2
Bipolar 1 - Manic episodes: Severe sx, over 1w, marked fxn impairment, psychotic features
Bipolar 2 - Hypomanic episodes: Less severe sx, over 4d, impairment not severe enough to be hospitalized, no psychotic features
Differentiating bipolar disorder and major depressive disorder w/ psychotic features vs schizophrenia vs schizoaffective disorder
Bipolar and MDD w/ psychotic features have psychosis only during mood disturbances
Schizophrenia has psychosis w/o mood disturbances
Schizoaffective has major depressive episode concurrent w/ schizophrenia sx
NMS management
Discontinue offending antipsychotic, supportive care
Add dopaminergic Rx (bromocriptine, amantadine) to reverse blockade if necessary
Nightmare disorder vs non-REM sleep terrors
Nightmares: Full awakening from REM w/ alertness and dream recall
Non-REM: Partial arousal, unresponsiveness, no recall of dream content
Postinfectious glomerulonephritis vs IgA nephropathy
PIGN: 1.5-3w post-infxn, more common in kids, gross hematuria
Low C3, elevated anti-streptolysin O/anti-DNAse B, subepithelial humps of C3 deposits
IgA nephropathy: within 5d of infxn, young adult males, recurrent gross hematuria
Nml complement, mesangial IgA deposits
First test w/ suspected acromegaly?
IGF-1 - Responsible for most of GH effects
GH is too variable to make decisions
Primary manifestations of Chagas’ disease
Megacolon/megaesophagus
Cardiac disease 2/2 prolonged protozoal myocarditis
Winter’s formula
For determining appropriate respiratory compensation for metabolic acidosis:
Expected paCO2 = 1.5 * [HCO3-] + 8 +/- 2
Weber test
Tuning fork on midline skull
Conductive hearing loss: Lateralizes to affected ear
Sensorineural hearing loss: Lateralizes to unaffected ear
Rinne test
Normally, tuning fork over mastoid, then in outside EAM until no longer heard
Abnormal if can’t hear outside EAM = Conductive hearing loss
Paranoid
Suspicious, distrustful, hypervigilant
Schizoid
Prefer loner, detached, unemotional
Schizotypal
Eccentric, odd thoughts/perceptions/behaviors
Antisocial
Disregards/violates others’ rights
Borderline
Chaotic relationships, sensitive to abandonment, labile mood, impulsive, inner emptiness, self-harm
Histrionic
Dramatic, superficial, attention-seeking
Narcissistic
Grandiose, lacks empathy
Avoidant
Avoids interaction due to fear of criticism/rejection
Dependent
Submissive, clingy, needs to be taken care of
Obsessive-compulsive personality disorder
Rigid, controlling, perfectionistic (ego-syntonic)
Acute dystonia, treatment
(EPS from blocking D2Rs)
Sudden sustained cntrxn of neck, mouth, tongue, eye mm
Treat w/ benztropine, diphenhydramine
Akathisia, treatment
(EPS from blocking D2Rs)
Subjective restlessness, inability to sit still
Treat w/ b-blocker (propranolol) or BZD (lorazepam)
Drug-induced Parkinsonism, treatment
(EPS from blocking D2Rs)
Gradual-onset tremor, rigidity, bradykinesia
Treat w/ benztropine, amantadine
Tardive dyskinesia, treatment
(EPS from blocking D2Rs)
Gradual onset mouth/face/trunk/extremity dyskinesia after 6m Rx
Remove offending agent, Clozapine least likely to cause issues
Somatic symptom disorder
Excessive anxiety/preoccupation w/ unexplained sx
Illness anxiety disorder
Fear of having serious dx despite few sx, neg evals
Conversion disorder
Neuro sx incompatible w/ known dx
Often acute onset assoc w/ stress
Factitious disorder
Intentional falsification or inducement of sx to assume sick role
Malingering
Falsification or exaggeration of sx to obtain external incentives
SSRIs, SE
Fluoxetine, paroxetine, sertraline, citalopram, escitalopram, fluvoxamine
Sexual SEs, SIADH
SNRIs, major SE
Venlafaxine, desvenlafaxine, duloxetine
Discontinuation/withdrawal syndrome
NDRI, CIs, benefits
Bupropion
CI - SZ disorder (Lowers seizure threshold), Bulimia (Worsens electrolyte abnmlities)
No sexual SEs
TCAs
Amitriptyline, nortriptyline
MAOIs
Phenelzine, tranylcypromine
Social anxiety disorder
Anxiety restricted to social/performance situations, fear of scrutiny/embarrassment
Panic disorder
Recurrent, unexpected panic attacks
Specific phobia
Excessive anxiety about specific object/situation
Generalized anxiety disorder
Chronic multiple worries
Wallenberg syndrome
Lateral medullary infarction from blocked vertebral a:
Vestibulocerebellar sx (vertigo, nystagmus, IL limb ataxia)
IL loss of face + CL loss of limbs P/T/CT
Dysarthria, dysphagia
IL Horner’s, loss of automatic respiration
Medial medullary syndrome
ASA or vertebral a occlusion
CL limb paralysis + IL CN XII (lick your wounds)
Medial mid-pontine infarction
CL ataxia, hemiparesis of face+trunk+limbs, variable loss of CL tactile+position
Gonococcal urethritis vs chlamydial urethritis, testing, pregnancy
Gonorrhea will gram stain w/ G- cocci in vast majority of cases
Chlamydia cannot be visualized or cultured - requires DNA amplification testing
Chlamydia is in std initial prenatal screening
Gonorrhea is only indicated for high risk preg women (under 25y, multiple partners, STI hx)
Auer rods are specific for?
AML
When to start COPD patients on home oxygen?
Uncomplicated: Resting PaO2 under 55 or O2sat under 88%
Complicated by cor pulmonale or Hct over 55%: Resting PaO2 under 59 or O2sat under 89%
How to assess ARDS severity
PaO2/FiO2 ratio
Under 300: ARDS
Under ~50: Severe ARDS
Syphilis treatment in those w/ penicillin allergies
If neurosyphilis, pregnant, or other treatment failures: Desensitize and use Pen G
If primary: Doxycycline x14d
Heart block and diastolic murmur in an IVDU?
Perivalvular abscess involving conducting tissues
Fluoxetine name, common SE
Prozac
Weight gain, birth defects (cardiac)
Paroxetine name, benefit
Paxil
Long half-life of 1-3d better for those who may have poor adherance
Buspirone mech
5-HT and D2R agonist
Anxiolytic
Felty syndrome
Triad of inflammatory arthritis, splenomegaly, and neutropenia
Most common in those with long-standing severe RA
Anemia of prematurity, cause, labs
Most common anemia in preterm infants
D/t low Epo, short RBC lifespan, and blood loss
Labs: low Hb, Hct, retics
Beckwith-Wiedemann syndrome cause, pres, complications, monitoring
D/t gene on c11
Hemihyperplasia, macrosomia, rapid growth, macroglossia, omphalocele/umbilical hernia
Increased risk of Wilms tumor, hepatoblastoma - monitor w/ AFP, US
McCune-Albright syndrome
5% of female precocious puberty, assoc w/ other endocrine abnmlities
3Ps: Precocious puberty, Pigmentation (cafe-au-lait spots), Polyostotic fibrous dysplasia (bone defects)
ALL
Lymphoblasts on smear lack peroxidase (myeloblasts) but do stain PAS+ and contain TdT
May also have pancytopenia, LAD, splenomegaly
HUS
Hemolytic anemia + thrombocytopenia + AKI
Most common in toddlers after diarrheal illness caused by Shiga-toxin producing bacteria
Legg-Calve-Perthes disease
Osteonecrosis of femoral head usually in boys 4-10yo
Slipped capital femoral epiphysis
Displaced femoral neck from femoral head
Most often in obese adolescents (12-14yo)
Transient synovitis
Mild chronic hip/knee pain of insidious onset (usually post-viral illness and max 4wk) w/ uneven gait W/O PATH ON X-RAY
(Dx of exclusion)
Kawasaki disease sx, treatment
5d of fever
B/l nonexudative conjunctivitis
Mucositis (strawberry tongue, no exudates)
Cervical LAD (often u/l)
Rash (generalized, erythematous, polymorphous)
Extremity changes (edema)
Treat w/ ASA and IVIG to reduce coronary artery aneurysm risk
Scarlet fever sx
Complication of untreated Strep pharyngitis: Fever Tonsillar exudates Cervical LAD Rash ("sandpaper" sparing palms/soles)
Niemann-Pick disease sx, cause
Sphingomyelinase deficiency 2-6m Areflexia HSM Cherry-red macula Hypotonia Dev regression
Tay-Sachs sx, cause
b-hexosaminidase A deficiency 2-6m Cherry-red macula Hypotonia Dev regression Hyperreflexia
NO HSM or areflexia
RTA 1 defect, cause, labs
Non-anion gap MetAcid
Poor H+ secretion into urine (distal RTA)
D/t genetic disorders, med tox, or autoimmune
Low-nml serum K
Urine pH over 5.5
RTA 2 defect, cause, labs
Non-anion gap MetAcid
Poor HCO3- resorption from urine (proximal RTA)
D/t Fanconi syndrome (glucosuria, phosphaturia, aminoaciduria)
Low-nml serum K
Urine pH under 5.5
RTA 4 defect, cause, labs
Non-anion gap MetAcid Aldosterone resistance D/t obstructive uropathy, congenital adrenal hyperplasia High serum K Urine pH under 5.5
Endometriosis
Pain 1-2wk prior to menses peaking before menstruation
Triad of dysmenorrhea, dyspareunia, infertility
REM sleep disorder sx, assoc
Complex motor behaviors during REM due to absent muscle atonia
Usually latter part of the night (non-REM is earlier)
Assoc w/ neuro degen in PD, Lewy body dementia
Bereavement major depressive episode treatment
Psychotherapy + SSRI
First trimester screen
Screens for trisomies 18, 21 risk (not diagnostic)
F/u w/ amniocentesis (15-20w) or CVS (10-13w) if abnml
Goal of HCV treatment
Limit risk for future liver damage - avoid IVDU, EtOH; HepA + B vac if not given
Causes of increased maternal serum AFP
Open neural tube defects
Ventral wall defects (omphalocele, gastroschisis)
Multiple gestation
Causes of decreased maternal serum AFP
Aneuploidy (esp. trisomies 21, 18)